Skip to main content
. Author manuscript; available in PMC: 2021 Feb 1.
Published in final edited form as: Gastroenterology. 2019 Oct 22;158(3):527–536.e7. doi: 10.1053/j.gastro.2019.10.019

Table 2.

Risk factors for development of gastric cancer using multivariable competing risk time to event model

SHR (95% Cl) P- value
Agea 1.13 (1.11–1.15) P<0.001
Method of H pylori diagnosis
 Positive diagnostic test REFERENCE 0.006
 RX, no serum Ab 0.95(0.82–1.10)
 ICD, no serum Ab 0.89(0.65–1.23)
 RX, with serum Ab 0.83(0.59–1.17)
 ICD, with serum Ab 0.75 (0.62–0.90)
Ethnicity
 Not Hispanic or Latino REFERENCE
 Hispanic or Latino 1.59(1.34–1.87) P<0.001
 Unknown 1.30 (1.08–1.55)
Race
 White REFERENCE
 Black or African American 2.00 (1.80–2.22) P<0.001
 American Indian or Alaskan Native 1.36(0.84–2.19)
 Asian 2.52(1.64–3.89)
 Native Hawaiian or other Pacific Islander 0.82(0.48–1.42)
 Unknown 1.08(0.91–1.29)
History of smoking 1.38(1.25–1.52) P<0.001
Female gender 0.52 (0.40–0.68) P<0.001
Poverty level of zip code where patient resided at H pylori diagnosis
 < 10% residing below poverty level REFERENCE
 10 − 24.9% residing below poverty level 0.86 (0.77–0.97) 0.09
 25 − 49.9% residing below poverty level 0.95(0.84–1.09)
 ≥50% residing below poverty level 0.99(0.76–1.29)
 Unknown 0.83(0.65–1.06)
a.

Age is per 5-year incremental increase in year

RX = prescription therapy; ICD = International Classification of Diseases (administrative codes); Ab = antibody